Following radical resection of gastroesophageal junction (GEJ) adenocarcinoma, a meta-analysis of individual data demonstrated better survival in patients treated with fluoropyrimidine regimens compared to surgery alone. ITACA-S trials is an Italian, no profit, multicentre, randomized, open-label, superiority phase III stydy aimed at evaluating whether a more intensive postoperative chemotherapy has better efficacy, when replaces fluoropyrimidine.
ITACA-S (Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach) Trial: comparison of a sequential treatment with irinotecan (cpt-11) + 5-fluorouracil (5-FU)/folinic acid (LV) followed by docetaxel and cisplatin versus a 5-FU/LV regimen as postoperative treatment for radically resected gastric cancer / Bajetta E; Floriani I; Bartolomeo M; Labianca R; Falcone A; Di Costanzo F; Comella G; Amadori D; Martoni A; Tortora G; Nitti D; Daniele B; Mini E; Rulli E; Cropalato di Tullio M; Santoro A; Casaretti R; Boni C; Pinotti G.; Bidoli P; Rosati G; Ravaioli A; Cantore M. - In: TUMORI. - ISSN 0300-8916. - STAMPA. - 3:(2012), pp. 1-1.
ITACA-S (Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach) Trial: comparison of a sequential treatment with irinotecan (cpt-11) + 5-fluorouracil (5-FU)/folinic acid (LV) followed by docetaxel and cisplatin versus a 5-FU/LV regimen as postoperative treatment for radically resected gastric cancer
DI COSTANZO, FRANCESCO;MINI, ENRICO;
2012
Abstract
Following radical resection of gastroesophageal junction (GEJ) adenocarcinoma, a meta-analysis of individual data demonstrated better survival in patients treated with fluoropyrimidine regimens compared to surgery alone. ITACA-S trials is an Italian, no profit, multicentre, randomized, open-label, superiority phase III stydy aimed at evaluating whether a more intensive postoperative chemotherapy has better efficacy, when replaces fluoropyrimidine.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
